Laserfiche WebLink
p <br /> td <br /> Page 2 <br /> April 1, 1996 RE Organic Analyses Lab : STK 631560 � <br /> Valley Wholesale Drugs Sampling Site G W_ Monitoring/Valley Wholesale Drugs <br /> r <br /> an <br /> c� <br /> ANALYTICAL RESULTS <br /> EthylTPH Gas MTBE <br /> j;Fg Benzene Benzene Toluene kylene w <br /> Sample _ r.D <br /> ID Description % Rec DLR RESULT I DLR RESULT DLR RESULT DLR RESULT I IaLR _-RESULT DLR --RES e <br /> 0.3 ND <br /> 0 3 RD 0 3 Co <br /> ND 0 3 IID D 05 ND <br /> 1 QA/QC Slank - STIC96032600L A 102 _. _._ _-- o0 <br /> 2 Wu Blank - 5TK960326010 B --- QED _- � <br /> 97 0 3 110 0 3 KD 0 3 ND 0 3 S U 110 <br /> ~ <br /> 3 KIS-2 B8 -- - - --- -- <br /> 4 QAfQL Blank - STK96040100A k - - --- -- 0 05 -ND _ 5 0 IID _ ►� <br /> 5 MW-2 88 ` <br /> --- <br /> 6 MW-2 BB "�- - 0 --- -� - 0 ---Np- - 0. O---iMD -- - 3 <br /> 95 --- _RD - --- <br /> 7 KW-2 - --- — _-_- - 0- _ 110 M - <br /> 9 MW-2 BB -- 0 3 -may 0 3 -- HD 0 3 NO 0 3 WD - <br /> 10 MW-3 BB _ 0 3 ..-RD --- --- - <br /> 0 05 -- ND --- <br /> 11 KW-3 BB --- - 0.3 RD 0 3 ND <br /> 12 QA oC Blank - STK96032BOUL A 9 0 3 7 --- --- --- 5 D KD <br /> 13 <br /> 14 3 B8 _ __ _------- 113_____ 3_�+ --12__ _0 (1*_3 _ N� 3 _� --µ12= 3�* --420 <br /> IW- <br /> Is MW-3 ---_ _ __. --- -- - .No_ <br /> 16 KW-2 BB0 3 IiD 0.3 ND 0 3 ND <br /> 101 0 3 -NO - - 0 05 ND <br /> 17 MW-1 68 <br /> -- --- 5 0 ND t <br /> 16 MW-a BB --- ' <br /> 19 KW-2 BB 111 60t 4700 60t 1000 60• 3400 60+-- 5100 --_ 0 50� Z4 <br /> za MW-1 --- -- --- __ - - -- ---- - - - <br /> 21 KW-1 - - - 5 0 <br /> 22 MW-2 w 49-- 0-3 ND 0 3 ND 0.3 KI) 0.3 ND 0 OS pD <br /> --- <br /> 23 Trip Blank --- --- --- --- <br /> 24 Trip Blank - --- --- 5 0 ND <br /> 25 MW-2 611 <br /> ugfL ugfL gtgfL ugf L <br /> Units Surrogate u4IL Wt. EPA 8020 EPIC 8015 EPA 8020 <br /> Analytical Method AR tX? EPA 8020 EPA 60x0 EPA 8'JZO <br /> hcceptable Range �'-125 <br /> No = 1lot Detected at or above the Detection Limit Reported (DLR)- = DLR adjusted because of dilutions, concentrat1cns, or platted se+ople <br /> Please see next page for comments <br />